These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

159 related items for PubMed ID: 7834187

  • 1. Differential inhibition of neuronal calcium entry and [3H]-D-aspartate release by the quaternary derivatives of verapamil and emopamil.
    Keith RA, Mangano TJ, DeFeo PA, Ernst GE, Warawa EJ.
    Br J Pharmacol; 1994 Oct; 113(2):379-84. PubMed ID: 7834187
    [Abstract] [Full Text] [Related]

  • 2. Inhibition of K(+)-evoked [3H]D-aspartate release and neuronal calcium influx by verapamil, diltiazem and dextromethorphan: evidence for non-L/non-N voltage-sensitive calcium channels.
    Mangano TJ, Patel J, Salama AI, Keith RA.
    Eur J Pharmacol; 1991 Jan 03; 192(1):9-17. PubMed ID: 1645678
    [Abstract] [Full Text] [Related]

  • 3. Effects of stimulus intensity on the inhibition by omega-conotoxin GVIA and neomycin of K(+_-evoked [3H]norepinephrine release from hippocampal brain slices and synaptosomal calcium influx.
    Keith RA, Horn MB, Piser TM, Mangano TJ.
    Biochem Pharmacol; 1993 Jan 07; 45(1):165-71. PubMed ID: 8381003
    [Abstract] [Full Text] [Related]

  • 4. gamma-Aminobutyric acid release from synaptosomes as influenced by Ca2+ and Ca2+ channel blockers.
    Carvalho CM, Santos SV, Carvalho AP.
    Eur J Pharmacol; 1986 Nov 12; 131(1):1-12. PubMed ID: 3816939
    [Abstract] [Full Text] [Related]

  • 5. Participation of intracellular sites in the action of Ca2+ channel blockers.
    White EJ, Bradford HF.
    Eur J Pharmacol; 1986 Nov 04; 130(3):243-8. PubMed ID: 3792448
    [Abstract] [Full Text] [Related]

  • 6. Gadolinium and neomycin block voltage-sensitive Ca2+ channels without interfering with the Na(+)-Ca2+ antiporter in brain nerve endings.
    Canzoniero LM, Taglialatela M, Di Renzo G, Annunziato L.
    Eur J Pharmacol; 1993 Apr 15; 245(2):97-103. PubMed ID: 8491259
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. The effects of (-)-daurisoline on Ca2+ influx in presynaptic nerve terminals.
    Lu YM, Liu GQ.
    Br J Pharmacol; 1990 Sep 15; 101(1):45-8. PubMed ID: 2282465
    [Abstract] [Full Text] [Related]

  • 9. Effects of Ca2+ channel blockers on Ca2+ translocation across synaptosomal membranes.
    Carvalho CA, Coutinho OP, Carvalho AP.
    J Neurochem; 1986 Dec 15; 47(6):1774-84. PubMed ID: 2430061
    [Abstract] [Full Text] [Related]

  • 10. Actions of neomycin on neuronal L-, N-, and non-L/non-N-type voltage-sensitive calcium channel responses.
    Keith RA, Mangano TJ, DeFeo PA, Horn MB, Salama AI.
    J Mol Neurosci; 1992 Dec 15; 3(3):147-54. PubMed ID: 1320922
    [Abstract] [Full Text] [Related]

  • 11. (S)-emopamil, a novel calcium and serotonin antagonist for the treatment of cerebrovascular disorders. 1st communication: pharmacological profile.
    Hofmann HP, Raschack M, Unger L.
    Arzneimittelforschung; 1989 Mar 15; 39(3):304-8. PubMed ID: 2757655
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Blockade by ifenprodil of high voltage-activated Ca2+ channels in rat and mouse cultured hippocampal pyramidal neurones: comparison with N-methyl-D-aspartate receptor antagonist actions.
    Church J, Fletcher EJ, Baxter K, MacDonald JF.
    Br J Pharmacol; 1994 Oct 15; 113(2):499-507. PubMed ID: 7834201
    [Abstract] [Full Text] [Related]

  • 15. Inhibition of neuronal Ca(2+) influx by gabapentin and subsequent reduction of neurotransmitter release from rat neocortical slices.
    Fink K, Meder W, Dooley DJ, Göthert M.
    Br J Pharmacol; 2000 Jun 15; 130(4):900-6. PubMed ID: 10864898
    [Abstract] [Full Text] [Related]

  • 16. Effects of calcium antagonists on KCl-evoked calcium uptake by rat cortical synaptosomes.
    Wei JW, Chiang DH.
    Gen Pharmacol; 1986 Jun 15; 17(3):261-5. PubMed ID: 3721183
    [Abstract] [Full Text] [Related]

  • 17. (S)-emopamil, a novel calcium and serotonin antagonist for the treatment of cerebrovascular disorders. 2nd communication: brain penetration, cerebral vascular and metabolic effects.
    Szabo L.
    Arzneimittelforschung; 1989 Mar 15; 39(3):309-14. PubMed ID: 2757656
    [Abstract] [Full Text] [Related]

  • 18. Brain voltage-sensitive calcium channel subtypes differentiated by omega-conotoxin fraction GVIA.
    Reynolds IJ, Wagner JA, Snyder SH, Thayer SA, Olivera BM, Miller RJ.
    Proc Natl Acad Sci U S A; 1986 Nov 15; 83(22):8804-7. PubMed ID: 2430302
    [Abstract] [Full Text] [Related]

  • 19. Characterization of K(+)-evoked [3H]D-aspartate outflow in the rat hippocampus in vitro.
    Simonato M, Bregola G, Muzzolini A, Bianchi C, Beani L.
    Neurochem Int; 1993 Dec 15; 23(6):555-60. PubMed ID: 8281124
    [Abstract] [Full Text] [Related]

  • 20. K(+)-Evoked [(3)H]D-aspartate release in rat spinal cord synaptosomes: modulation by neuropeptide Y and calcium channel antagonists.
    Martire M, Altobelli D, Maurizi S, Preziosi P, Fuxe K.
    J Neurosci Res; 2000 Dec 01; 62(5):722-9. PubMed ID: 11104511
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.